These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11533760)

  • 21. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
    Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
    Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
    Kumar KS; Russo MW; Borczuk AC; Brown M; Esposito SP; Lobritto SJ; Jacobson IM; Brown RS
    Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
    Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C in dialysed patients--what is the current optimal treatment?
    Kes P; Basic-Jukic N
    Kidney Blood Press Res; 2007; 30(3):156-61. PubMed ID: 17446715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
    Mandac JC; Chaudhry S; Sherman KE; Tomer Y
    Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Viral hepatitis C in patients with renal disease].
    Contreras AM
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S88-92. PubMed ID: 12712863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The experience of interferon-based treatments for hepatitis C infection.
    Hopwood M; Treloar C
    Qual Health Res; 2005 May; 15(5):635-46. PubMed ID: 15802540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of acute hepatitis C.
    Alberti A; Boccato S; Vario A; Benvegnù L
    Hepatology; 2002 Nov; 36(5 Suppl 1):S195-200. PubMed ID: 12407594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
    Jain AB; Eghtesad B; Venkataramanan R; Fontes PA; Kashyap R; Dvorchik I; Shakil AO; Kingery L; Fung JJ
    Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterobacter cloacae graft infection/bacteremia in a hemodialysis patient.
    Cunha BA; Theodoris AC; Yannelli B
    Am J Infect Control; 2000 Apr; 28(2):181-3. PubMed ID: 10760226
    [No Abstract]   [Full Text] [Related]  

  • 35. Is HCV a nosocomial infection in haemodialysis patients?
    Sungur C
    Nephrol Dial Transplant; 1994; 9(7):875-6. PubMed ID: 7970136
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon alpha treatment and thyroid dysfunction.
    Tomer Y; Blackard JT; Akeno N
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):1051-66; x-xi. PubMed ID: 17983936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute recurrent suppurative thyroiditis in childhood].
    Zarfin Y; Theodor E; Zwas TS
    Harefuah; 1981 Feb; 100(3):130-1. PubMed ID: 7262681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychiatric and cognitive problems associated to hepatitis C and its treatment with interferon].
    Caneo R C; González T M; Repetto L PB; Soza R A
    Rev Med Chil; 2010 Nov; 138(11):1431-40. PubMed ID: 21279258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cases of interferon-alpha and interferon-beta-induced thyroiditis.
    Nonchev BI
    Folia Med (Plovdiv); 2010; 52(3):5-12. PubMed ID: 21053668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute rejection of non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin.
    Cavero-Escribano T; Morales-Ruiz E; Manzano-Peña MT; Muñoz-Gómez R; Hernández-Martínez E; Gutiérrez-Martínez E; Praga-Terente M
    Nefrologia; 2014; 34(2):230-4. PubMed ID: 24658199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.